Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for QuidelOrtho Corporation (QDEL : NSDQ)
 
 • Company Description   
QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO.

Number of Employees: 6,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $22.74 Daily Weekly Monthly
20 Day Moving Average: 1,292,790 shares
Shares Outstanding: 68.08 (millions)
Market Capitalization: $1,548.18 (millions)
Beta: 0.75
52 Week High: $41.40
52 Week Low: $19.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.31% -15.57%
12 Week -18.08% -18.18%
Year To Date -20.38% -20.76%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9975 SUMMERS RIDGE ROAD
-
SAN DIEGO,CA 92121
USA		 ph: 858-552-1100
fax: 858-453-4338		 ir@quidel.com http://www.quidelortho.com
 
 • General Corporate Information   
Officers
Brian J. Blaser - President and Chief Executive Officer
Kenneth F. Buechler - Chairman of the Board
Joseph M. Busky - Chief Financial Officer
John R. Chiminski - Director
Evelyn S. Dilsaver - Director

Peer Information
QuidelOrtho Corporation (BJCT)
QuidelOrtho Corporation (CADMQ)
QuidelOrtho Corporation (APNO)
QuidelOrtho Corporation (UPDC)
QuidelOrtho Corporation (IMTIQ)
QuidelOrtho Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 219798105
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/06/26
Share - Related Items
Shares Outstanding: 68.08
Most Recent Split Date: (:1)
Beta: 0.75
Market Capitalization: $1,548.18 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.54 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $2.18 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 10.43
Trailing 12 Months: 10.73
PEG Ratio: -
Price Ratios
Price/Book: 0.80
Price/Cash Flow: 1.20
Price / Sales: 0.57
EPS Growth
vs. Year Ago Period: -26.98%
vs. Previous Quarter: -42.50%
Sales Growth
vs. Year Ago Period: 2.23%
vs. Previous Quarter: 3.39%
ROE
12/31/25 - 5.91
09/30/25 - 5.75
06/30/25 - 5.29
ROA
12/31/25 - 2.37
09/30/25 - 2.49
06/30/25 - 2.43
Current Ratio
12/31/25 - 1.50
09/30/25 - 1.78
06/30/25 - 1.12
Quick Ratio
12/31/25 - 0.90
09/30/25 - 0.98
06/30/25 - 0.62
Operating Margin
12/31/25 - 5.27
09/30/25 - 5.72
06/30/25 - 5.77
Net Margin
12/31/25 - -41.46
09/30/25 - -42.53
06/30/25 - -16.10
Pre-Tax Margin
12/31/25 - -40.57
09/30/25 - -41.86
06/30/25 - -14.89
Book Value
12/31/25 - 28.27
09/30/25 - 29.98
06/30/25 - 41.13
Inventory Turnover
12/31/25 - 2.50
09/30/25 - 2.51
06/30/25 - 2.57
Debt-to-Equity
12/31/25 - 1.29
09/30/25 - 1.23
06/30/25 - 0.74
Debt-to-Capital
12/31/25 - 56.28
09/30/25 - 55.08
06/30/25 - 42.59
 

Powered by Zacks Investment Research ©